Olon USA supports the pharmaceutical market with a robust generics portfolio, a deep bench of technical expertise, and a strategically distributed global manufacturing network. With 14 sites across multiple continents, Olon offers the flexibility and capacity needed to meet the evolving demands of both established and emerging markets.
Generics and Proprietary Process Products
Olon differentiates between traditional generics and what it calls Proprietary Process Products (PPP). These are APIs developed using Olon’s own IP and technology, serving both the generic and innovative pharmaceutical markets. While traditional generics are based on off-patent molecules, PPPs represent a strategic push into innovation-driven generics with earlier market entry paths such as Paragraph IV filings.
The PPP approach also includes investment in novel polymorphs and differentiated processes, giving customers earlier access to markets with more secure supply chains. Olon’s capabilities make it possible to take on risk-managed product launches and create value in a highly competitive space.
Adapting to a Competitive and Fragmented Market
The U.S. generics market has undergone significant consolidation and transformation over the past 15 years. Fewer dominant players now compete alongside an increasing number of entrants from India and Europe. This shifting landscape demands a partner with the ability to pivot quickly and scale efficiently. Olon’s global infrastructure enables flexible allocation of production capacity based on market trends and individual project requirements.
Olon’s recent acquisitions demonstrate its commitment to expanding both capacity and capability. New facilities in France, Italy, and India enhance the company’s ability to respond to customer needs with fermentation capabilities, expanded API production, and site redundancy that strengthens the overall supply chain.
Flexible Manufacturing Across 14 Sites
A core strength of Olon is the ability to match projects with the most appropriate manufacturing site based on capacity, technology, and regulatory requirements. Products can move from early-stage development to high-volume production without sacrificing quality or consistency. In some cases, a single product may be registered across multiple sites to ensure redundancy and scale flexibility.
Batch sizes across sites range from a few hundred grams to over 500 kilograms, allowing Olon to support everything from clinical development to commercial supply. This wide variability gives customers access to seamless scale-up with reduced risk.
Supporting Evolving Regulatory Pathways
Olon also supports 505(b)(2) applications, which require different formulations of existing APIs. These non-ANDA products involve added complexity, such as new dosage forms and delivery methods, often with distinct clinical and regulatory demands. Olon is equipped to meet these challenges with the same rigor it applies to traditional generics.
The ability to manufacture both ANDA and 505(b)(2) products under one organization streamlines supply chains and accelerates timelines for pharmaceutical customers seeking to repurpose APIs.
What Makes a Strong Partner
The ideal customer for Olon has clear forecasting and a mid- to long-term pipeline strategy. Reliable forecasting enables efficient manufacturing planning, better use of capacity, and cost optimization. While not all customers operate with precise forecasts, Olon’s teams develop rolling projections up to 24 months in advance to ensure readiness for fluctuations in demand.
Olon supports projects that may span multiple years and can adapt as projects mature. This flexibility makes the organization an effective partner for both early-stage and established pharmaceutical companies.
Supply Chain Durability Through Global Footprint
With multiple validated sites for API production, Olon can ensure supply chain continuity even during disruptions. Products can be transferred between facilities to meet rising demand or respond to shifting global dynamics. This capability is a key differentiator in a market where supply stability is increasingly tied to competitive success.
Start Your Next Generic or PPP Project with Confidence
Olon USA combines a global footprint, technical depth, and commercial insight to deliver reliable, compliant, and flexible manufacturing solutions for generics and proprietary process products. With a network built for resilience and scale, Olon is ready to meet your API development and production needs with precision.
To learn how Olon USA can support your next generic or proprietary project, contact the team today and start a conversation about your goals.